https://www.marketscreener.com/quote/stock/ISIS-PHARMACEUTICALS-INC-9734/news/ISIS-Pharmaceuticals-AstraZeneca-and-Isis-Pharmaceuticals-to-Co-Develop-Targeted-Oligonucleotide-D-19386189/?utm_source=telegram&utm_medium=social&utm_campaign=share